Evidence mapPaperPMID 40107260Full record

ReviewArquivos de neuro-psiquiatria2025

Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.

Vitor Tumas, Marcelo Jhonatan Aureliano, Carlos Roberto de Melo Rieder, Artur Francisco Schumacher Schuh, Henrique Ballalai Ferraz, Vanderci Borges, Maria Carolina Soares, Dayany Leonel Boone, Carolina Candeias da Silva, Mariana Cavalcanti Costa and 17 more

Abstract readReview
In one paragraph

Review in Arquivos de neuro-psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Vitor TumasUniversidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto SP, Brazil.ORCID 0000-0003-2402-2709
Marcelo Jhonatan AurelianoUniversidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, Ribeirão Preto SP, Brazil.ORCID 0009-0001-6148-8666
Carlos Roberto de Melo RiederUniversidade Federal de Ciências da Saúde de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil.ORCID 0000-0003-2950-7211
Artur Francisco Schumacher SchuhUniversidade Federal do Rio Grande do Sul, Departamento de Farmacologia, Porto Alegre RS, Brazil.ORCID 0000-0002-8722-0908
Henrique Ballalai FerrazUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID 0000-0002-3821-1407
Vanderci BorgesUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID 0000-0002-8723-2757
Maria Carolina SoaresUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID 0009-0007-0324-1052
Dayany Leonel BooneUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID 0000-0001-9932-3528
Carolina Candeias da SilvaUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID 0000-0003-2661-779X
Mariana Cavalcanti CostaUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID 0000-0002-9605-2280
Delson José da SilvaUniversidade Federal de Goiás, Hospital das Clínicas, Centro de Referência em Doença de Parkinson e Transtornos do Movimento (CerMov), Goiânia GO, Brazil.ORCID 0000-0002-1558-6943
Aracelle Victor do CarmoUniversidade Federal de Goiás, Hospital das Clínicas, Centro de Referência em Doença de Parkinson e Transtornos do Movimento (CerMov), Goiânia GO, Brazil.ORCID 0000-0003-2430-487X
Luana de Rezende MikaelUniversidade Federal de Goiás, Hospital das Clínicas, Centro de Referência em Doença de Parkinson e Transtornos do Movimento (CerMov), Goiânia GO, Brazil.ORCID 0009-0000-4767-3462
Bruno Lopes Santos-LobatoUniversidade Federal do Pará, Instituto de Ciências Biológicas, Laboratório de Neuropatologia Experimental, Belém PA, Brazil.ORCID 0000-0001-9321-5710
Ana Lucia Zuma RossoUniversidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Serviço de Neurologia Prof. Sérgio Novis, Rio de Janeiro RJ, Brazil.ORCID 0000-0002-2545-715X
Celmir de Oliveira VilaçaUniversidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Serviço de Neurologia Prof. Sérgio Novis, Rio de Janeiro RJ, Brazil.ORCID 0000-0002-2631-8303
Pedro Braga-NetoUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Medicina Clínica, Fortaleza CE, Brazil.ORCID 0000-0001-9186-9243
André Borges Ferreira GomesUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Medicina Clínica, Fortaleza CE, Brazil.ORCID 0000-0003-0504-4072
Camila Gonçalves Monteiro CarvalhoUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Medicina Clínica, Fortaleza CE, Brazil.ORCID 0000-0001-5257-5971
Grace Helena LetroPontifícia Universidade Católica de Campinas, Centro de Ciências da Vida, Ambulatório de Neurologia Clínica, Setor de Distúrbios do Movimento, Campinas SP, Brazil.ORCID 0000-0002-3815-9514
Denise Hack NicarettaUniversidade Federal do Estado do Rio de Janeiro, Escola de Medicina e Cirurgia, Serviço de Neurologia, Rio de Janeiro RJ, Brazil.ORCID 0000-0001-7812-2735
Marcus Vinicius Della ColettaUniversidade do Estado do Amazonas, Departamento de Neurologia, Manaus AM, Brazil.ORCID 0000-0002-3368-8492
Egberto Reis BarbosaUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.ORCID 0000-0002-6996-9130
Rubens Gisbert CuryUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.ORCID 0000-0003-2113-2187
Francisco Eduardo Costa CardosoUniversidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Medicina Interna, Belo Horizonte MG, Brazil.ORCID 0000-0003-0808-0116
Sarah Teixeira CamargosUniversidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Medicina Interna, Belo Horizonte MG, Brazil.ORCID 0000-0001-9829-6783
Ignacio Fernandez MataCleveland Clinic Foundation, Lerner Research Institute, Genomic Medicine Institute, Cleveland OH, United States.ORCID 0000-0003-1198-0633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The etiology of Parkinson's disease (PD) is complex and multifactorial, depending on interactions involving environmental/lifestyle and genetic factors. The genetic aspects of the disease are becoming well characterized, while the environmental factors still need further investigation. In the present narrative review, we have described the most concrete evidence of associations between environmental factors and the risk of developing PD. Physical activity, healthy dietary patterns, smoking, and caffeine intake are protective factors against PD. Head trauma, consumption of milk and dairy products, and pesticide exposure were associated with a higher risk of developing PD. The associations of alcohol consumption, living in rural areas, farming, and consumption of well water with PD are still controversial. Results of several studies strongly suggest that diabetes mellitus is a risk factor for the development of PD, as well as the pre-diabetic state. Lower serum levels of uric acid were associated with an increased risk of developing PD and with worse clinical features and faster progression of symptoms. The protective effects of nonsteroidal antiinflammatory drugs use are controversial. Several other factors were potentially associated with the risk of developing PD: environmental pollutants such as organic solvents, exposure to sunlight, vitamin D deficiency, bullous pemphigoid, bipolar disorder, inflammatory bowel disease, irritable bowel syndrome, certain infections and agents, and essential tremor. Environmental factors are important risk markers for the development of PD. Understanding these risks and protective factors could lead to the implementation of risk-modifying actions for PD.

Indexed as

Environmental ExposureParkinson DiseaseHumansLife StyleRisk Factors

Identifiers

PMID40107260
PMCPMC11922612

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.